In the past, clinical trials on GLP-1 drugs have proven their Gains for a secondary prevention Resource for heart problems (CVD), indicating they will lessen the likelihood of the coronary heart assault or stroke in https://europeantimes.news/2024/08/belgium-battle-drugs-alcohol-hope/